Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score-a prospective observational study

Markus Kneihsl1, Egbert Bisping2, Daniel Scherr2

  • 1Department of Neurology, Medical University of Graz, Graz, Austria.

Insights

A new clinical risk score helps identify patients with cryptogenic stroke (CS) who may have undiagnosed atrial fibrillation (AF). This score aids in selecting patients for cardiac monitoring, improving diagnosis rates.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Diagnostics

Background:

  • Atrial fibrillation (AF) is frequently undiagnosed in cryptogenic stroke (CS) patients due to limited cardiac monitoring availability.
  • There is a need to pre-select CS patients who would benefit most from extended cardiac rhythm monitoring.
  • A clinical risk score was developed to predict AF in CS patients.

Purpose of the Study:

  • To develop and evaluate a clinical risk score for predicting atrial fibrillation (AF) in cryptogenic stroke (CS) patients.
  • To assess the score's performance over a 1-year follow-up period.
  • To improve the diagnostic yield of cardiac monitoring in CS patients.

Main Methods:

  • A risk score (0-16 points) was created using variables associated with occult AF, including age, NT-proBNP, ECG/echocardiographic features, and brain imaging markers.
  • 150 CS patients admitted between March 2018 and August 2019 were prospectively followed for 1 year for AF detection.
  • The score's predictive performance was evaluated using sensitivity, specificity, and negative predictive value.

Main Results:

  • During 1-year follow-up, 24 (16%) of 150 CS patients were diagnosed with AF.
  • The AF Risk Score (cutoff ≥4) demonstrated a 92% sensitivity and 67% specificity for 1-year AF prediction.
  • The score achieved an excellent negative predictive value of 98%, with only two patients scoring <4 diagnosed with AF.

Conclusions:

  • A clinical risk score effectively predicts 1-year AF risk in CS patients with high sensitivity and negative predictive value.
  • The score aids in selecting CS patients for cardiac rhythm monitoring.
  • Further validation in external cohorts with continuous monitoring is necessary to confirm generalizability.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
163
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
52
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
88
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
69
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
128